Background Genitourinary syndrome of menopause (GSM) is a widespread condition with a
great impact on quality of life and self-image. Aim We aimed to systematically review the …

Vulvovaginal atrophy (VVA) is a chronic progressive disease involving the female genital
apparatus and lower urinary tract. This condition is related to hypoestrogenism consequent …

Vulvovaginal atrophy (VVA) is a chronic progressive condition that involves the genital and
lower urinary tracts, related to the decrease of serum estrogenic levels when menopause …

In recent years, LASER has been introduced as a minimally invasive treatment for a broad
range of vaginal and vulvar symptoms and diseases. However, the efficacy and safety of …

Objective: The aim of this study is to assess the efficacy of microablative fractional CO 2
laser therapy for genitourinary syndrome of menopause (GSM) management, when three …

Introduction The FDA issued a statement on July 30, 2018, expressing concern over the
marketing of lasers and energy‐based devices to promote “vaginal rejuvenation.” The FDA …

Vulvovaginal atrophy (VVA) or genitourinary syndrome of menopause (GSM) may affect up
to 90% of menopausal women. Features include vulvovaginal atrophy, vulvovaginal laxity …

Background Genitourinary syndrome of menopause (GSM) negatively affects sexual
function and quality of life. Techniques like laser and radiofrequency are being used to …

Objectives Genitourinary syndrome of menopause (GSM) combines the conditions of
vulvovaginal atrophy (VVA) and urinary tract dysfunction, which is a result of urethral …

Objectives To determine the efficacy and predictive factors for the success of Er: YAG laser
treatment in patients with urinary incontinence (UI). Methods Eighty-two patients with UI …